Mon, November 8, 2021
Sun, November 7, 2021
Fri, November 5, 2021
Thu, November 4, 2021
Wed, November 3, 2021
Tue, November 2, 2021

Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $14 on, Nov 4th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-14-on-nov-4th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Decreased Target from $16 to $14 on, Nov 4th, 2021.

Brian has made no other calls on BCRX in the last 4 months.



There are 4 other peers that have a rating on BCRX. Out of the 4 peers that are also analyzing BCRX, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Maury Raycroft of "Jefferies" Downgraded from Strong Buy to Hold on, Friday, August 6th, 2021


These are the ratings of the 3 analyists that currently disagree with Brian


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $30 on, Friday, August 6th, 2021
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Increased Target to $23 on, Friday, August 6th, 2021
  • Brian Cheng of "Cantor Fitzgerald" Initiated at Buy and Held Target at $21 on, Tuesday, August 3rd, 2021

Publication Contributing Sources